ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

IPS Ipso Ventures

1.425
0.00 (0.00%)
22 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Ipso Ventures LSE:IPS London Ordinary Share GB00B1GDWB47 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.425 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Ipso Ventures Share Discussion Threads

Showing 1351 to 1374 of 2275 messages
Chat Pages: Latest  55  54  53  52  51  50  49  48  47  46  45  44  Older
DateSubjectAuthorDiscuss
21/9/2011
16:06
NOT a T tradeable stock - its one for a hold preferably medium term ---
tomboyb
21/9/2011
13:29
Moving up nicely again, news imminent maybe?
27macca
21/9/2011
13:28
I added at 3.25 but not showing
johncraven
21/9/2011
13:22
WINS on the BID - They had been on the offer throughout the last few days.
tomboyb
21/9/2011
13:13
No - but take your arguments elsewhere!
tomboyb
21/9/2011
13:11
tomboyb

I'm no pump and dumper ?

kinghorm23
21/9/2011
13:11
Kingphorm - i'll think i add you to that list as well -
tomboyb
21/9/2011
13:10
ello ello ello what going on here then...
chesty1
21/9/2011
13:09
So long as the pump and dump crew of topinfo/falia and moreforus stay away
this time !

kinghorm23
21/9/2011
13:07
looks like this might get going bourght a few more today.
johncraven
21/9/2011
11:16
Cheers Tom,

Yeap! agree with you for ATUK - Huge Potential.

I'm doing my research on IPS now.

Nick

nick2008
21/9/2011
11:12
Hi Nick - I don't comment too much on my investments but there are'nt too many like ATUK - If ATUK can deliver what is given on the broker note then there is significant upside to be had - It is dependent on management first and foremost which in my books makes it a worthwhile investment -
tomboyb
21/9/2011
11:04
Cheers tom.
lufc5
21/9/2011
10:53
Hi Tomboyb,
Looking into this as potential investment. Not bought yet......
R u still in atuk? haven't seen you there for sometime.

Nick

nick2008
21/9/2011
10:12
Thank you tomboy, much better.

DC

daicaprice
21/9/2011
10:08
Updated with Daily charts -- --
tomboyb
21/9/2011
09:54
Daily chart??????
lufc5
21/9/2011
09:49
Which is why i have a medium term stake here - they talked on cash flow yet they did not research the company at all. £155k now for a minimum of 12 months BEFORE any disposals.

Secondly - the value now is in the equity of the company. dyor.

tomboyb
21/9/2011
09:31
To me IPS looks like another AGL in time so have bought a few to hold long term.
wskill
21/9/2011
09:27
L2 shifted now 2 v 1 - buying at full quote --
tomboyb
21/9/2011
07:33
Cashburn? In case you can't read - the placing of £155k is enough for a minimum 12 months. Yes - that is before any disposals IPS has and management have significantly been restructured.
tomboyb
21/9/2011
00:06
Give it up Tom... it is on life support.. the paymetn to therakind may be a few hundred £000 and IPS get 36% eventually -cash burn is killingand if revenues dont come in then it is fund raising!!!!
electrick
20/9/2011
22:07
Therakind has:

secured agreement of a Paediatric Investigation Plan (PIP) for its first product, Buccolam™, an oromucosal (buccal) solution of midazolam hydrochloride for the rapid treatment of children suffering from acute epileptic seizures. A clinical study, sponsored by Therakind, was recently conducted in Germany and the authorised product is expected to be available in 2011.
secured "fast track" marketing approval status from the MHRA (UK Medicines and Healthcare products Regulatory Agency) for its second product, a collaborative project with another UK pharma company, for paediatric pain control. Clinical trials are ongoing.
a strong pipeline of further products, actively progressing with other partners to secure regulatory approvals.

tomboyb
20/9/2011
22:03
Buccolam



"The European Commission granted a marketing authorisation valid throughout the European Union for Buccolam on 5 September 2011."

Therakind due that milestone payment on marketing approval - Now lodged at the european medicenes agency.

tomboyb
Chat Pages: Latest  55  54  53  52  51  50  49  48  47  46  45  44  Older

Your Recent History

Delayed Upgrade Clock